Skip to main content

Introduction

  • Chapter
  • First Online:
Nocturia

Abstract

Nocturia is defined as waking during the night at least once to urinate. It has additionally been suggested that a nocturia-related void is preceded and followed by sleep [1]. Whether sleep must follow a nocturia-related void is not entirely clear. Thus, for example, if someone arises an hour earlier than planned with the urge to void but could not return to sleep, nocturia seems evident but would not be considered as such if one rigidly adheres to the notion that a nocturia-related void must be followed by sleep. In the same sense, nocturnal voiding with failure to return to sleep leading to a second void which is then followed by sleep may cause confusion in designation of nocturia severity. Voiding during hours of sleep resulting from awakening for reasons other than the urge to void is not considered nocturia, although from a practical standpoint it is difficult to keep track of “convenience voids” at night as opposed to true nocturia-related voids. Thus, most studies of nocturia in the literature from a practical standpoint include voiding for all reasons during sleep hours.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. van Kerrebroeck P, Abrams P, Chaikin D, et al. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:179.

    Article  PubMed  Google Scholar 

  2. Kripke DF, Garfinkel L, Wingard DL, et al. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 2002;59:131.

    Article  PubMed  Google Scholar 

  3. Bing MH, Moller LA, Jennum P, et al. Prevalence and bother of nocturia, and causes of sleep interruption in a Danish population of men and women aged 60–80 years. BJU Int. 2006;98:599.

    Article  PubMed  Google Scholar 

  4. Beers T. Flexible schedules and shift work: replacing the ‘9-to-5’ workday? Mon Labor Rev. 2000;23:33–40.

    Google Scholar 

  5. Blanker MH, Bohnen AM, Groeneveld FP, et al. Normal voiding patterns and determinants of increased diurnal and nocturnal voiding frequency in elderly men. J Urol. 2000;164:1201.

    Article  PubMed  CAS  Google Scholar 

  6. Weiss JP, Blaivas JG, Stember DS, et al. Evaluation of the etiology of nocturia in men: the nocturia and nocturnal bladder capacity indices. Neurourol Urodyn. 1999;18:559.

    Article  PubMed  CAS  Google Scholar 

  7. Asplund R. The nocturnal polyuria syndrome (NPS). Gen Pharmacol. 1995;26:1203.

    Article  PubMed  CAS  Google Scholar 

  8. Kirkland JL, Lye M, Levy DW, et al. Patterns of urine flow and electrolyte excretion in healthy elderly people. Br Med J. 1983;287:1665.

    Article  CAS  Google Scholar 

  9. van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S, et al. The standardisation of terminology in nocturia: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:179–83.

    Article  PubMed  Google Scholar 

  10. Matthiesen TB, Rittig S, Norgaard JP, et al. Nocturnal polyuria and natriuresis in male patients with nocturia and lower urinary tract symptoms. J Urol. 1996;156:1292.

    Article  PubMed  CAS  Google Scholar 

  11. Weiss JP, Stember DS, Chaikin DC, Blaivas JG. Evaluation of the etiology of nocturia in men: the nocturia and nocturnal bladder capacity indices. Neurourol Urodyn. 1999;18:559–65.

    Article  PubMed  CAS  Google Scholar 

  12. Burton C, Parsons M, Weiss JP, Coats A. Reference values for the nocturnal bladder capacity index. Neurourol Urodyn. 2011;30:52–7.

    Article  PubMed  Google Scholar 

  13. Weiss JP, Blaivas JG, Jones M, et al. Age related pathogenesis of nocturia in patients with overactive bladder. J Urol. 2007;178:548.

    Article  PubMed  Google Scholar 

  14. Weiss JP, Blaivas JG, Stember DS, et al. Nocturia in adults: classification and etiology. Neurourol Urodyn. 1997;16:401.

    Google Scholar 

  15. Tikkinen KA, Auvinen A, Johnson 2nd TM, Weiss JP, Keränen T, Tiitinen A, et al. A systematic evaluation of factors associated with nocturia – the population-based FINNO study. Am J Epidemiol. 2009;170(3):361–8.

    Article  PubMed  Google Scholar 

  16. Adam P. Evaluation and management of diabetes insipidus. Am Fam Physician. 1997;55:2146.

    PubMed  CAS  Google Scholar 

  17. Abraham L, Hareendran A, Mills IW, Martin ML, Abrams P, Drake MJ, et al. Development and validation of a quality-of-life measure for men with nocturia. Urology. 2004;63(3):481–6.

    Article  PubMed  Google Scholar 

  18. International Consultation on Incontinence modular Questionnaire (ICIQ). [online]. 2006. Available from: http://www.iciq.net/structure.html.

  19. Buysse DJ, Reynolds III CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.

    Article  PubMed  CAS  Google Scholar 

  20. Tikkinen KAO, Johnson TM, Tammela TL, et al. Nocturia frequency, bother and quality of life: how often is too often? A population-based study in Finland. Eur Urol. 2010;57(3):488–96.

    Article  PubMed  Google Scholar 

  21. Nakagawa H, Niu K, Kaiho Y, Ikeda Y, Arai Y. Mortality in the elderly correlates with the frequency of nighttime voiding: results of a 5 year prospective cohort study in Japan. J Urol. 2010;183(4):e1–2.

    Article  Google Scholar 

  22. Asplund R, Aberg H. Nocturnal micturition, sleep and well-being in women of ages 40–64 years. Maturitas. 1996;24(1–2):73–81.

    Article  PubMed  CAS  Google Scholar 

  23. Kupelian V, Fitzgerald MP, Kaplan SA, Norgaard JP, Chiu GR, Rosen RC. Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey. J Urol. 2011;185(2):571–7.

    Article  PubMed  Google Scholar 

  24. Holm-Larsen T, Weiss JP, Langkilde LK. Economic burden of nocturia in the US adult population. J Urol. 2010;183(4):e1.

    Article  Google Scholar 

  25. Ikehara S et al. Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study. Sleep. 2009;32(3):295–301.

    PubMed  Google Scholar 

  26. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension. 2006;47(5):833–9.

    Article  PubMed  CAS  Google Scholar 

  27. Bliwise DL, Foley DJ, Vitiello MV, Ansari FP, Ancoli-Israel S, Walsh JK. Nocturia and disturbed sleep in the elderly. Sleep Med. 2009;10(5):540–8.

    Article  PubMed  Google Scholar 

  28. Cardozo L et al. Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. J Urol. 2004;172:1919–24.

    Article  PubMed  CAS  Google Scholar 

  29. Herschorn S, Swift S, Guan Z, Carlsson M, Morrow JD, Brodsky M, et al. Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial. BJU Int. 2010;105(1):58–66.

    Article  PubMed  CAS  Google Scholar 

  30. Dmochowski R et al. Randomized, double-blind, placebo-controlled trial of flexible-dose fesoterodine in subjects with overactive bladder. Urology. 2010;75(1):62–8.

    Article  PubMed  Google Scholar 

  31. Brubaker L, Fitzgerald MP. Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms. Int Urogynecol J. 2007;18:737–41.

    Article  Google Scholar 

  32. Rackley R, Weiss JP, Rovner ES, Wang JT, Guan Z. Nighttime dosing with tolterodine reduces bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology. 2006;67:731–6.

    Article  PubMed  Google Scholar 

  33. Koseoglu H et al. Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapy. Urology. 2006;67:1188–92.

    Article  PubMed  Google Scholar 

  34. Speakman M. Efficacy and safety of Tamsulosin OCAS. BJU Int. 2006;98 suppl 2:13–7.

    Article  CAS  Google Scholar 

  35. Johnson-II TM, Jones K, Williford WO, Kutner MH, Issa MM, Lepor H. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the department of veterans affairs cooperative study trial. J Urol. 2003;170:145–8.

    Article  Google Scholar 

  36. Johnson-II TM, Burrows PK, Kusek JW, Nyberg LM, Tenover JL, Lepor H, et al. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. J Urol. 2007;178:2045–51.

    Article  Google Scholar 

  37. Kaplan SA, Roehrborn CG, Rovner ES, Carlsson M, Bavendam T, Guan Z. Tolterodine and Tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder. A randomized controlled trial. JAMA. 2006;296:2319–28.

    Article  PubMed  CAS  Google Scholar 

  38. Bruskewitz RC, Larsen EH, Madsen PO, Dorflinger T. 3-year follow-up of urinary symptoms after transurethral resection of the prostate. J Urol. 1986;136:613.

    PubMed  CAS  Google Scholar 

  39. Yoshimura K et al. Nocturia and benign prostatic hyperplasia. Urology. 2003;61:786–90.

    Article  PubMed  Google Scholar 

  40. Cai T et al. Impact of surgical treatment on nocturia in men with benign prostatic obstruction. BJU Int. 2006;98:799–805.

    Article  PubMed  Google Scholar 

  41. Oelke M, Bachmann A, Descazeaud M, et al. Guidelines on conservative treatment of non-neurogenic male LUTS. EAU; 2010 http://www.uroweb.org/gls/pdf/BPH%202010.pdf.

  42. Andersson K-E et al. The pharmacological treatment of nocturia. BJU Int. 2002;90 Suppl 3:25–7.

    Article  PubMed  CAS  Google Scholar 

  43. Weiss JP, Yea C, Nathadwarawala M, Marks BK, Imnadze M. Novel non-peptide pharmacologic therapy for nocturia in men. J Urol. 2010;183(4):e590.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeffrey P. Weiss MD, FACS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Weiss, J.P. (2012). Introduction. In: Weiss, MD, FACS, J., Blaivas, MD, J., Van Kerrebroeck, MD, PhD, MMSc, P., Wein, MD, FACS, PhD(hon), A. (eds) Nocturia. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1156-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-1156-7_1

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-1155-0

  • Online ISBN: 978-1-4614-1156-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics